5 citations
,
August 2025 in “Biomedicines” This comprehensive review addresses the cutaneous and oral mucosal adverse events (AEs) associated with breast cancer treatments, which significantly affect patients' quality of life and treatment adherence. It highlights the importance of early detection and multidisciplinary management of these toxicities, which can arise from chemotherapy, targeted therapy, hormonal therapy, radiotherapy, and immunotherapy. The review discusses the clinical presentation, pathophysiology, incidence, and management strategies for these AEs, emphasizing the need for evidence-based prevention and emerging approaches like nanoparticle-based delivery systems. By focusing on both cutaneous and oral complications, the review aims to enhance therapeutic experiences and outcomes for breast cancer patients through integrated care strategies.
52 citations
,
February 2006 in “Archives of Dermatology” Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.
141 citations
,
September 2016 in “European Journal of Dermatology” Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.
179 citations
,
October 2018 in “American Journal of Clinical Dermatology” Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.
2 citations
,
December 2023 in “Journal of clinical immunology” Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.